![]() |
|
| |
Molecular Medicine is the international, peer-reviewed, biomedical journal published by the Feinstein Institute for Medical Research (New York). Molecular Medicine strives to understand normal body functioning and disease pathogenesis at the molecular level, which may allow researchers and physician-scientists to use that knowledge in the design of specific molecular tools for disease diagnosis, treatment, prognosis, and prevention. Manuscripts submitted to the journal should maintain this focus and describe the implications for human disease, at a level approachable by the broad readership of Molecular Medicine. The 2010 Journal Citation Report (JCR), showing impact factors calculated from citations of articles published in 2009 and 2008, lists Molecular Medicine with an impact factor of 5.908, putting it in the top 5% of publications. JCR category rankings are as follows: Medicine, Research & experimental 11/106, Cell Biology 40/178, Biochemistry & Molecular Biology 44/286. Molecular Medicine publishes work in the format of original research articles, review articles, editorials, commentaries and letters to the editor covering emerging concepts in the interdisciplinary field of molecular medicine. Molecular Medicine places high priority on rapid publication. All content is published free online, ahead of print, within an average of 8 days after acceptance on our Web site www.molmed.org. Following acceptance, papers are posted rapidly to PubMed, with an e-publication ahead of print citation. Molecular Medicine is an open access journal and does not embargo content.
HIGHLIGHTS of the recent literature include: |
![]() |
|